The current pharma business model is unsustainable
World of DTC Marketing
SEPTEMBER 7, 2022
While that sounds encouraging, most cancer drugs launched between 2009 and 2014 cost more than USD 100,000 annually. This leads to a question; “where does it end?” COVID-19 has not impacted the number of launches in the oncology space, as 2020 and 2021 have seen similar rates of drug launches as in 2019.
Let's personalize your content